Bausch + Lomb Corp
NYSE:BLCO
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
13.6
20.93
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Revenue Breakdown
Breakdown by Geography
Bausch + Lomb Corp
Total Revenue:
4.1B
USD
|
United States And Puerto Rico:
1.9B
USD
|
Other:
655m
USD
|
China:
344m
USD
|
France:
210m
USD
|
Japan:
187m
USD
|
Germany:
147m
USD
|
United Kingdom:
121m
USD
|
Canada:
110m
USD
|
Russia:
106m
USD
|
Spain:
85m
USD
|
Italy:
82m
USD
|
Mexico:
68m
USD
|
Poland:
51m
USD
|
South Korea:
46m
USD
|
Breakdown by Segments
Bausch + Lomb Corp
Total Revenue:
4.1B
USD
|
Product Sales:
4.1B
USD
|
Vision Care:
2.5B
USD
|
Devices:
1.7B
USD
|
Otc:
1.6B
USD
|
Surgical:
767m
USD
|
Pharmaceuticals:
618m
USD
|
Branded And Other Generics:
252m
USD
|
Other Revenues:
15m
USD
|